Yao, J., Wang, A., Wang, X., Zhang, L., Zhu, Y., Ou, Y., . . . Yang, Y. (2019). Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation. Onco Targets Ther.
Citação norma ChicagoYao, Jing-hao, An-sheng Wang, Xiao-jing Wang, Lu Zhang, Yue Zhu, Yu-rong Ou, Zi-shu Wang, and Yan Yang. "Complete Response to Crizotinib in a Metastatic Adenocarcinoma of Unknown Primary Harboring MET Amplification and NTRK1 Co-occurring Mutation." Onco Targets Ther 2019.
ציטוט MLAYao, Jing-hao, et al. "Complete Response to Crizotinib in a Metastatic Adenocarcinoma of Unknown Primary Harboring MET Amplification and NTRK1 Co-occurring Mutation." Onco Targets Ther 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.